ifosfamide

网络  异环磷酰胺; 异磷酰胺; 匹服平; 和异环磷酰胺; 异环磷醯胺

化学



双语例句

  1. Objective To evaluate the therapeutic effect and side effects of combined chemotherapy with home made Ifosfamide ( IFO) in the retreatment of advanced cancers.
    目的探讨以国产异环磷酰胺为主的联合化疗方案治疗晚期复治肿瘤的疗效和毒副作用。
  2. Clinical observation of continuous-infusion with high-dose ifosfamide plus adriamycin on advanced soft tissue sarcomas
    大剂量异环磷酰胺持续静滴联合阿霉素治疗进展期软组织肉瘤的临床观察
  3. Epirubicin combined with ifosfamide in the treatment of advanced soft tissue sarcoma
    异环磷酰胺联合表阿霉素治疗晚期软组织肉瘤27例疗效分析
  4. Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase ⅱ study
    顺铂、异环磷酰胺和长春酰胺联合用药治疗非小细胞肺癌的Ⅱ期研究
  5. Ifosfamide with PHA-LAK cell adoptive immunotherapy in advanced recurrent ovarian epithelial cancer
    异环磷酰胺联合自体PHA-LAK细胞治疗晚期复发卵巢上皮癌的疗效观察
  6. The role of ifosfamide in the treatment of soft tissue sarcomas
    异环磷酰胺在软组织肉瘤治疗中的地位
  7. Objective To evaluate the efficacy and toxicity of ITP ( ifosfamide+ perarubicin+ cisplatin) and NP ( vinorelbine+ cisplatin) regimens in the treatment of advanced non small cell lung cancer ( NSCLC).
    目的比较ITP(异环磷酰胺+吡喃阿霉素+顺铂)与NP(去甲长春花碱+顺铂)方案治疗晚期非小细胞肺癌的临床有效率和毒副作用。
  8. Effect of ifosfamide and Vp-16 on patients with small cell lung cancer and impact of blood vessels in mesenchyma on chemotherapeutic sensitivity
    异环磷酰胺和Vp-16治疗小细胞肺癌的疗效及癌间质血管数量对化疗敏感性的影响
  9. Objective: To observe the therapeutic effects and toxicity reaction of Ifosfamide ( IFO) combined with Cisplatin ( DDP) or Etoposide ( VP-16) for the treatment of advanced lung cancer.
    目的:观察异环磷酰胺(IFO)联合顺铂(DDP)或足叶乙甙(VP16)治疗晚期肺癌的近期疗效和毒性反应。
  10. [ Conclusion] It is shown that ifosfamide-based combination chemotherapy is active and tolerable in the various tumors as first and second line treatment.
    〔结论〕异环磷酸胺联合化疗作为一、二线治疗对多种晚期恶性肿瘤均有一定疗效。
  11. Purpose: To investigate the treatment effect and toxicity of regimen containing ifosfamide ( IFO) and etoposide ( VP16) on relapse ovarian carcinoma.
    目的:研究异环磷酰胺(IFO)与依托泊苷(VP16)联合治疗复发卵巢癌的疗效和毒性反应。
  12. A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer
    应用异环磷酰胺、紫杉醇和卡铂治疗晚期和复发性宫颈癌的Ⅰ期研究
  13. Purpose and Methods: The mutagenicity of Cyclophosphamide ( CP) and Ifosfamide ( IFO) was studied using Ames test and SOS chromotest.
    目的与方法:本文通过Ames试验和SOS显色试验比较了环磷酰胺(CP)与异环磷酰胺(IFO)的致突变作用。
  14. This study was to investigate the efficacy and toxicity of the modified MAID regimen in ASTS treatment. METHODS: In the modified regimen, adriamycin ( ADR) was substituted with tetrahydropyranyl adriamycin ( THP-ADR) and the application of ifosfamide ( IFO) was modified.
    本研究通过用四氢吡喃阿霉素(THP-ADR)替代MAID方案中的ADR和改良异环磷酰胺(IFO)用法治疗晚期软组织肉瘤,观察改良方案的疗效和不良反应。
  15. Continuous-infusion high dose ifosfamide as salvage treatment for pre-treated soft tissue sarcoma in teenage patients
    大剂量异环磷酰胺联合方案治疗青少年晚期软组织肉瘤
  16. The preliminary results of mis study suggest that Ifosfamide+ VP16+ Cisplatin may be effective in the treatment of advanced stage soft tissue sarcoma.
    此项研究的初步结果表明异环磷酰胺+VP(-16)+DDP在晚期软组织肉瘤的治疗上是有效的。
  17. Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: A case report and literature review
    1例阿霉素与异环磷酰胺治疗原发性恶性阴道黑色素瘤的病例报道及文献回顾
  18. Objective To explore the feasibility of treatment for osteosarcoma with chemotherapy regimen composed of methotrexate, ifosfamide, doxorubicin ( ADR)( MMIA).
    目的探讨以大剂量甲氨蝶呤、异环磷酰胺和阿霉素组成的(methotrexate,ifosfamide,doxorubicin,ADR),MMIA方案治疗骨肉瘤的可行性。
  19. Objective To compare the response rate and the side effects of the regimen NEC ( vinorelbine, etoposide and carboplatin) with IEC ( ifosfamide, etoposide and carboplatin) in the treatment of advanced non small cell lung cancer ( NSCLC).
    目的比较NEC方案与IEC方案治疗晚期非小细胞肺癌的疗效及不良反应。
  20. Objective To study the effectiveness and toxicity of ifosfamide ( IFO) combined with venorelbine ( VRL) in patients with nasopharyngeal carcinoma ( NPC) refractory to platinum based chemotherapy.
    目的探讨异环磷酰胺(IFO)联合长春瑞滨(VRL)治疗对铂类耐药的复发和/或转移的鼻咽癌的疗效和毒副反应。
  21. Navelbine, ifosfamide and cisplatin combined chemotherapy for advanced non-small cell lung cancer
    异长春花碱加异环磷酰胺加顺铂联合化疗治疗晚期非小细胞肺癌
  22. Objective To evaluate the clinical efficacy and toxicity of ifosfamide ( IFO) combination chemotherapy in patients with advanced gynecologic malignancies.
    目的对异环磷酰胺(IFO)联合化疗治疗晚期妇科恶性肿瘤进行临床疗效和毒性评价。
  23. Gene expression profiles showing hepatotoxicity in Balb/ c mice exposed to cyclophosphamide and ifosfamide
    环磷酰胺和异环磷酰胺Balb/c小鼠肝脏毒性的基因表达谱
  24. Purpose and Methods: The frequencies of micronucleus in polychromatic erythrocytes as well as the PCE/ NCE ratios in maternal bone marrow and in fetal liver induced by Cyclophsphamide ( CP) and Ifosfamide ( IFO) were studied in pregnancy mice.
    目的与方法:本文研究了受孕小鼠尾静脉注射环磷酰胺(CP)和异环磷酰胺(IFO)对母鼠骨髓和胎肝微核频率及嗜多染红细胞与正成红细胞比率(PCE/NCE)的影响。
  25. Objectives: To investigate the treatment effect and toxicity of regimen contained ifosfamide ( IFO) and carboplatinum ( CBP) and pingyangmycinum ( PYM) on relapse cervical cancer.
    目的:研究异环磷酰胺(IFO)、卡铂(CBP)和平阳霉素(PYM)联合治疗复发性宫颈癌的疗效和毒性反应。
  26. Phase II clinical study of ifosfamide in lymphomas and small cell lung cancer
    异环磷酰胺治疗恶性淋巴瘤及小细胞型肺癌的Ⅱ期临床观察
  27. Chemotherapy plays a pivotal role in the treatment of osteosarcoma. Currently, the main chemotherapy agents for osteosarcoma comprise cisplatin, doxorubicin, ifosfamide and high dose of methotrexate.
    化疗在骨肉瘤治疗中的地位举足轻重,当前普遍使用的化疗药物有顺铂、阿霉素、异环磷酰胺及大剂量的甲氨蝶呤。
  28. Conclusion: The combination of vinorelbine ( NVB) and Ifosfamide ( IFO) possesses better short term efficacy, acceptable toxicity, This protocol is worthy to be warranted as salvage for relapsed or refractory non-Hodgkin ′ s lymphoma.
    结论:长春瑞滨联合异环磷酰胺方案对治疗复发或难治性非霍奇金淋巴瘤患者尤其中、晚期患者有较好的近期疗效,毒副反应轻,是值得进一步验证的解救性化疗方案。
  29. All patients have received Chemotherapy with at least one of following medicine: cisplatin, carboplatin, ifosfamide, doxorubicin.
    所有患者经过顺铂、卡铂、环磷酰胺、阿霉素等其中一种化疗药物治疗后的患者。